Subcellular mapping of the protein landscape of SARS-CoV-2 infected cells for target-centric drug repurposing
J. M. Kaimal, M. Tampere, T. H. Le, U. Axelsson, H. Xu, H. Axelsson, A. Backstrom, F. Marabita, E. Moussaud-Lamodiere, D. Njenda, C. O. Sepulveda, W. Ouyang, B. Seashore-Ludlow, C. Vernersson, A. Mirazimi, , C. Stadler
The paper uses immunofluorescence to analyze host protein changes in SARS-CoV-2 infection and identifies three drugs that reduce antiviral activity.
bioRxiv · Mar 29, 2022 · PreprintCell Biology